Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Matagrin

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
JAMA Ophthalmology|February 15, 2024
Follow-Up of Bilateral Iridoschisis in a Patient With Alport SyndromeBenjamin Matagrin, Emilie Agard, Corinne Dot
Retinal Cases & Brief Reports|December 22, 2025
CORRESPONDENCELucas Sejournet, Ines Fenniri, Benjamin Matagrin, et al.
The Journal of Biological Chemistry|August 10, 2013
VKORC1L1, an enzyme rescuing the vitamin K 2,3-epoxide reductase activity in some extrahepatic tissues during anticoagulation therapyAbdessalem Hammed, Benjamin Matagrin, Gabriele Spohn, et al.
Scientific Reports|September 15, 2018
Missense mutation of VKORC1 leads to medial arterial calcification in ratsArnaud Michaux, Benjamin Matagrin, Jean-Valéry Debaux, et al.
Journal of Clinical Pharmacology|May 20, 2014
Identification of VKORC1 genotype leading to resistance to tecarfarinBenjamin Matagrin, Adrien Montagut-Romans, Marlene Damin, et al.
FEBS Open Bio|June 18, 2013
New insights into the catalytic mechanism of vitamin K epoxide reductase (VKORC1) - The catalytic properties of the major mutations of rVKORC1 explain the biological cost associated to mutationsBenjamin Matagrin, Ahmed Hodroge, Adrien Montagut-Romans, et al.
Ophthalmology and Therapy|July 21, 2025
Continuous versus Intermittent Use of Tear Substitutes in Patients Treated with Anti-VEGF for Neovascular Age-Related Macular Degeneration: The TREDIA StudyHéloïse Torres-Villaros, Audrey Giocanti-Aurégan, Serge Doan, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|September 13, 2025
Comparative Analysis of Long-Term Outcomes of Submacular Hemorrhage in AMD: A Real-Life StudyNicolas Chirpaz, Benjamin Matagrin, Lucas Gauthier, et al.
Eye (London, England)|November 14, 2025
Long-term evolution of retinal atrophy after focal laser photocoagulation of telangiectatic capillaries: LyoMAC3 studyDamien Vingerder, Lucas Sejournet, Benoit Allignet, et al.
BMC Ophthalmology|June 13, 2026
Selective laser trabeculoplasty is effective in controlling steroid-induced OHT after 0.19 µg Fluocinolone acetonide implant, a long-term outcome of 15 eyesSamuel Chacun, Jeremy Billant, Axel Goissaud, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
JAMA Ophthalmology|February 15, 2024
Follow-Up of Bilateral Iridoschisis in a Patient With Alport SyndromeBenjamin Matagrin, Emilie Agard, Corinne Dot
Retinal Cases & Brief Reports|December 22, 2025
CORRESPONDENCELucas Sejournet, Ines Fenniri, Benjamin Matagrin, et al.
The Journal of Biological Chemistry|August 10, 2013
VKORC1L1, an enzyme rescuing the vitamin K 2,3-epoxide reductase activity in some extrahepatic tissues during anticoagulation therapyAbdessalem Hammed, Benjamin Matagrin, Gabriele Spohn, et al.
Scientific Reports|September 15, 2018
Missense mutation of VKORC1 leads to medial arterial calcification in ratsArnaud Michaux, Benjamin Matagrin, Jean-Valéry Debaux, et al.
Journal of Clinical Pharmacology|May 20, 2014
Identification of VKORC1 genotype leading to resistance to tecarfarinBenjamin Matagrin, Adrien Montagut-Romans, Marlene Damin, et al.
FEBS Open Bio|June 18, 2013
New insights into the catalytic mechanism of vitamin K epoxide reductase (VKORC1) - The catalytic properties of the major mutations of rVKORC1 explain the biological cost associated to mutationsBenjamin Matagrin, Ahmed Hodroge, Adrien Montagut-Romans, et al.
Ophthalmology and Therapy|July 21, 2025
Continuous versus Intermittent Use of Tear Substitutes in Patients Treated with Anti-VEGF for Neovascular Age-Related Macular Degeneration: The TREDIA StudyHéloïse Torres-Villaros, Audrey Giocanti-Aurégan, Serge Doan, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|September 13, 2025
Comparative Analysis of Long-Term Outcomes of Submacular Hemorrhage in AMD: A Real-Life StudyNicolas Chirpaz, Benjamin Matagrin, Lucas Gauthier, et al.
Eye (London, England)|November 14, 2025
Long-term evolution of retinal atrophy after focal laser photocoagulation of telangiectatic capillaries: LyoMAC3 studyDamien Vingerder, Lucas Sejournet, Benoit Allignet, et al.
BMC Ophthalmology|June 13, 2026
Selective laser trabeculoplasty is effective in controlling steroid-induced OHT after 0.19 µg Fluocinolone acetonide implant, a long-term outcome of 15 eyesSamuel Chacun, Jeremy Billant, Axel Goissaud, et al.
Pageof 2